New biomarker may predict sepsis death risk
NCT ID NCT07356739
First seen Jan 23, 2026 · Last updated May 07, 2026 · Updated 13 times
Summary
This study explored whether levels of a natural substance, Phoenixin-14, can help predict which sepsis patients in the ICU are at higher risk of dying. Researchers measured Phoenixin-14 in the blood of 77 adults with sepsis and compared it to other markers. The goal was to see if Phoenixin-14 could be a better tool for guiding treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS - TO REDUCE MORTALITY IN THE INTENSIVE CARE UNIT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Firat University Hospital
Elâzığ, 23100, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.